Children's Hospital of Fudan University: Mucocutaneous Lymph Node Syndrome trials
The registry lists 11 Mucocutaneous Lymph Node Syndrome studies with Children's Hospital of Fudan University as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 5Phase 4 2No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki DiseaseNot yet recruitingNCT07686770Phase 2/3
- Statins Study in Children of Acute Kawasaki Disease With Coronary Artery AbnormalitiesRecruitingNCT07530640Phase 3
- Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 YearsRecruitingNCT06993636
- Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki DiseaseRecruitingNCT06978439Phase 4
- Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki DiseaseRecruitingNCT05643651Phase 4
- Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki DiseaseWithdrawnNCT04535518Phase 3
- Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki DiseaseCompletedNCT04078568Phase 3
- Statins Study in Kawasaki Disease Children With Coronary Artery AbnormalitiesCompletedNCT03915795
- Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017CompletedNCT03880929
- Different Doses of IVIG for Kawasaki DiseaseCompletedNCT02439996Phase 3
- Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012CompletedNCT02317913